ALEMBIC LACOSAMIDE lacosamide 200 mg film-coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

lacosamide, Quantity: 200 mg

Tilgjengelig fra:

Alembic Pharmaceuticals Australia Pty Ltd

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: colloidal anhydrous silica; crospovidone; magnesium stearate; hyprolose; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; macrogol 6000; macrogol 400; indigo carmine aluminium lake

Administreringsrute:

Oral

Enheter i pakken:

14, 56

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Alembic Lacosamide (lacosamide) tablets are indicated as: ? monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. ? add-on therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 4 years and older. ? add-on therapy in the treatment of primary generalised tonic-clonic seizures in patients with idiopathic generalised epilepsy aged 4 years and older.

Produkt oppsummering:

Visual Identification: Blue, oval, film-coated tablets debossed with "L426" on one side and plain on other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Autorisasjon status:

Registered

Autorisasjon dato:

2021-05-11